Biolase (BIOL) Tops Q2 EPS by 5c

Biolase (NASDAQ: BIOL) reported Q2 EPS of ($0.12), $0.05 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $2.9 million versus the consensus estimate of $2.09 million.

For earnings history and earnings-related data on Biolase (BIOL) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• Alta Mesa Resources (AMR) Misses Q2 EPS by 128c
• Johnson Outdoors (JOUT) Tops Q3 EPS by 49c